Osteoporosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Reasons to buy the ‘Osteoporosis’ market forecast report:

• The report provides an overview of osteoporosis, including epidemiology, symptoms, diagnosis, and disease management.
• It includes annualized osteoporosis therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2023 to 2033.
• The report covers strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications of these factors for the osteoporosis therapeutics market.
• Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for osteoporosis treatment. The most promising candidates in late-stage development are profiled.
• The report analyzes the current and future market competition in the global osteoporosis therapeutics market. It includes an insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

How is our ‘Osteoporosis in Major Markets’ report unique from other reports in the market?

• Develop and design your in-licensing and out-licensing strategies by reviewing pipeline products and technologies and identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the 7MM osteoporosis therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM osteoporosis therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

We recommend this valuable source of information to anyone involved in:

• ​​​​​​​Pharmaceutical/Biotech/Drug Manufacturing Companies (Big Pharma, Small Biotech, Start-ups, etc.),
• Pharmaceutical Industry Suppliers (e.g., Consulting Companies, CMOs, CDMOs, CROs, Technology Vendors)
• Pharma Manufacturers/Distributors (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)
• Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organizations
• Clinical Research Organizations (CROs)/Hospitals, Healthcare Organizations (HTA Bodies, Reimbursement Groups and Payers, Government Healthcare Organizations)
• Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)

To Get a Snapshot of the Osteoporosis Market Report

Download a Free Report Sample

Osteoporosis Market Report Overview

The Osteoporosis major market sales across the 7MM was $10.5 billion in 2023  and will grow at a compound annual growth rate (CAGR) of more than 5% between 2023 and 2033. The increased use of Evenity across the 7MM accelerated by growing physician familiarity and clinical experience following the recent launch will propel the market growth.

Osteoporosis Market Outlook, 2023-2033 ($ Billion)

Buy the Full Report to Know More about the Osteoporosis Major Market Forecast, Download a Free Report Sample

The Osteoporosis market research report provides a granular forecast growth analysis for both global and regional markets through 2033. The report covers an exhaustive study of the leading players, current treatment options, and driving factors for the market growth. Furthermore, the pipeline valuation analysis and information on the market’s unmet needs and opportunities will help in determining potential business possibilities.

Osteoporosis Market Segmentation by Countries

A few of the key countries wherein the Osteoporosis major market is prevalent are the US, France, Germany, Italy, Spain, the UK, and Japan. In 2023, the US accounted for the highest Osteoporosis market share in the 7MM because of an increase in the number of osteoporosis patients, due to the increase in the aging population worldwide.

Osteoporosis Market Analysis by Countries, 2023 (%)

Buy the Full Report for More Country Insights into the Osteoporosis Market

Download a Free Report Sample

Osteoporosis Market Segmentation by Class

A few of the key classes in the Osteoporosis major market are anti-resorptive agents, parathyroid hormones, selective estrogen receptor modulators, sclerostin inhibitors, and hormone replacement therapy. The highest-selling drug class was anti-resorptive drugs in 2033 followed by the sclerostin inhibitor drug class.

US Osteoporosis Market Analysis by Class, 2023 (%)

Buy the Full Report for More Class Insights into the Osteoporosis Market

Download a Free Report Sample

Osteoporosis Market - Competitive Landscape

A few of the major players in the Osteoporosis market are:

• Radius
• Pfizer
• Lilly
• Entera Bio

Anabolic therapies such as Forteo (teriparatide) is currently the leading anabolic across the 7MM and is anticipated to take market share from anti-resorptive therapies during the forecast period. In addition, Entera Bio’s oral teriparatide, named EB613, may offer a potential solution as the first oral daily formulation of teriparatide with the same amino acid sequence as Forteo.

Osteoporosis Market Analysis by Players

Buy the Full Report to Know More about Companies in the Osteoporosis Market

Download a Free Report Sample

Segments Covered in the Report

Osteoporosis Country Outlook (Value, $ Billion, 2023-2033)

• The US
• France
• Germany
• Italy
• Spain
• The UK
• Japan

Osteoporosis Class Outlook (Value, $ Billion, 2023-2033)

• Anti-resorptive Agents
• Parathyroid Hormones
• Selective Estrogen Receptors Modulators
• Sclerostin Inhibitor
• Hormone Replacement Therapy